the problem with cryptocurrency- Top People searches

Tongfu Microelectronics traded 2.24 million shares at a discount of 60.0768 million yuan today. Tongfu Microelectronics traded 2.24 million shares at a discount of 60.0768 million yuan today, accounting for 3.32% of the total turnover of the day, and the transaction price was 26.82 yuan, which was 9.97% lower than the market closing price of 29.79 yuan.The Southern CSI A500ETF Link Fund was added with Y share, which was included in the list of individual pensions. Four products from southern fund were shortlisted for individual pensions, including the Southern CSI A500ETF Link Fund, and Y share was added with code 022918. Its target ETF-CSI A500ETF South (159352) has received a net inflow of funds for 38 consecutive days, with the latest scale approaching 19 billion yuan. According to the data of China Merchants Securities Fund Evaluation Center, in the past 10 years, South Stock ETF has been the most accurate in tracking, ranking first in its kind. Investors can borrow the layout of the A500ETF South (159352) and its linked funds (A 022434, C 022435, Y 022918).German Foreign Minister: Ukraine needs hard security.

CITIC Securities: The resonance between supply and demand of medical beauty accelerates the space expansion, and the difference in operating ability promotes the evolution of the industry structure. CITIC Securities Research Report stated that the medical beauty industry has both medical and consumption attributes, and the medical attribute has strong product-driven characteristics, while the consumption attribute has high operating ability requirements. The medical beauty botulinum toxin track is also affected by the dual attributes of medicine and consumption: 1) The increase in penetration rate, the acceleration of compliance substitution and the extension of indications have brought about high demand for medical beauty botulinum toxin, and with the recent supply expansion, the industry scale has experienced high growth; 2) The iteration of product innovation is slow, brand barriers are created through marketing, doctors are empowered through direct sales, and control is strengthened to enhance product competitiveness. Recently, a variety of medical botulinum toxins in China have been approved, and the promotion of low-priced products is expected to push up the penetration rate, and enterprises with strong operational capabilities will enter the market or promote the evolution of the pattern.Ankaiwei: More than 10 million chips with computing power have been shipped. According to An Kai Micro Interactive Platform, since the first generation of chips with lightweight computing power were mass-produced and shipped in 2022, more than 10 million chips with computing power have been shipped.President of STELLANTIS Europe: If you want to avoid EU fines in 2025, you should either increase the sales of electric vehicles or reduce the production of gasoline vehicles.

Li Tie's case will be pronounced in the first instance tomorrow. The court has informed his defender of the well-known football player Li Tie, the former head coach of China National Men's Football Team (hereinafter referred to as "China Men's Football Team"), that the case will be pronounced in public by the Intermediate People's Court of Xianning City, Hubei Province tomorrow, that is, December 13, 2024, Beijing time. In the previous court hearing, although Li Tie said that he "pleaded guilty and repented", he did not "plead guilty and admit punishment". (Economic Observer)The tenth batch of national procurement officially opened, and the number of enterprises and varieties involved reached a record high. The tenth batch of centralized drug procurement organized by the state officially accepted the application materials of enterprises at 8: 00 this morning at No.398 Zhanyuan Road, Nanqiao New Town, Fengxian District, Shanghai. This centralized procurement involved 62 varieties and 263 product specifications, and the number of enterprises and varieties involved reached a record high. Among them, 33 enterprises competed for nine short-listed oral sustained-release formulations of sitagliptin. There are also a number of varieties that are billions in the market of public hospitals, such as doxorubicin hydrochloride liposome injection, cefoperazone injection, piperacillin injection, compound α -ketoacid oral sustained-release dosage form, norepinephrine injection and aspirin oral sustained-release dosage form. The sales scale in sample hospitals last year all exceeded 2 billion yuan. Hengrui Pharma, Kelun Pharmaceutical, Unacon and Zhengda Tianqing participated with many varieties. Note: According to the tenth batch of national adoption documents released before, the tenth batch of national adoption rules have changed a lot, such as canceling the protection mechanism of 50% price reduction and increasing the fuse recovery mechanism by 1.8 times, and the number of B-certified enterprises affects the number of final finalists.Japan's semiconductor sector rose collectively, with ADVANTEST up nearly 5%, DISCO up over 2% and Renesas Electronics up over 1%.